Frequency vs. Time in HD Survival

Which matters more for HD--the number of treatments per week, or the length of each treatment? A retrospective registry study from the ANZDATA database looked at survival among 16,944 non-indigenous adult patients in Australia and New Zealand from 2001 to 2015. After controlling for frequency, patients with 5+ hour long treatments had significantly better survival than those whose treatments <5 hours. However, controlling for duration, increasing frequency did not boost survival.

Read the abstract » | (added 06/13/2019)

Tags: Anzdata, Session Frequency, Session Duration, Survival, End Stage Kidney Disease

Related Journal Articles

Anzdata
Session Frequency
Session Duration
Survival
End Stage Kidney Disease